Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cogent Biosciences (COGT) Revenue (2017 - 2020)

Historic Revenue for Cogent Biosciences (COGT) over the last 4 years, with Q3 2020 value amounting to $312000.0.

  • Cogent Biosciences' Revenue fell 6941.18% to $312000.0 in Q3 2020 from the same period last year, while for Jun 2021 it was $312000.0, marking a year-over-year decrease of 9869.28%. This contributed to the annual value of $7.9 million for FY2020, which is 6501.62% down from last year.
  • Cogent Biosciences' Revenue amounted to $312000.0 in Q3 2020, which was down 6941.18% from $528000.0 recorded in Q2 2020.
  • Over the past 5 years, Cogent Biosciences' Revenue peaked at $15.3 million during Q4 2019, and registered a low of $312000.0 during Q3 2020.
  • For the 4-year period, Cogent Biosciences' Revenue averaged around $3.2 million, with its median value being $2.1 million (2017).
  • As far as peak fluctuations go, Cogent Biosciences' Revenue soared by 30178.71% in 2019, and later plummeted by 8317.4% in 2020.
  • Over the past 4 years, Cogent Biosciences' Revenue (Quarter) stood at $2.1 million in 2017, then soared by 79.23% to $3.8 million in 2018, then surged by 301.79% to $15.3 million in 2019, then tumbled by 97.96% to $312000.0 in 2020.
  • Its Revenue was $312000.0 in Q3 2020, compared to $528000.0 in Q2 2020 and $7.0 million in Q1 2020.